Necessity is the mother of invention and the evolutionary force driving the success of in vitro fertilization

Author(s):  
Alison F Bartolucci ◽  
John J Peluso

Abstract During the last few decades, millions of healthy children have been born with the aid of in vitro fertilization (IVF). This success belies the fact that IVF treatment is comprised of a complex series of interventions starting with a customized control ovarian stimulation protocol. This is followed by the induction of oocyte maturation, the retrieval of mature oocytes and in vitro fertilization, which often involves the microinjection of a single sperm into the oocyte. After fertilization, the resulting embryos are cultured for up to 7 days. The best embryos are transferred into the uterus where the embryo implants and hopefully develops into a healthy child. However, frequently the best embryos are biopsied and frozen. The biopsied cells are analyzed to identify those embryos without chromosomal abnormalities. These embryos are eventually thawed and transferred with pregnancy rates as good if not better than embryos that are not biopsied and transferred in a fresh cycle. Thus, IVF treatment requires the coordinated efforts of physicians, nurses, molecular biologists and embryologists to conduct each of these multifaceted phases in a seamless and flawless manner. Even though complex, IVF treatment may seem routine today, but it was not always the case. In this review the evolution of human IVF is presented as a series of innovations that resolved a technical hurdle in one component of IVF while creating challenges that eventually lead to the next major advancement. This step-by-step evolution in the treatment of human infertility is recounted in this review.

2002 ◽  
Vol 78 (3) ◽  
pp. 515-519 ◽  
Author(s):  
Arieh Raziel ◽  
Shevach Friedler ◽  
Morey Schachter ◽  
Esti Kasterstein ◽  
Deborah Strassburger ◽  
...  

2007 ◽  
Vol 88 ◽  
pp. S152
Author(s):  
E.B. Johnston-MacAnanny ◽  
A.J. DiLuigi ◽  
L.L. Engmann ◽  
D.B. Maier ◽  
C.A. Benadiva ◽  
...  

2010 ◽  
Vol 27 (3) ◽  
pp. 157-160 ◽  
Author(s):  
Midori Yoshizawa ◽  
Carlos Manuel Ulloa Ulloa ◽  
Danilda Hufana-Duran ◽  
Eufrocina Atabay ◽  
Peregrino G Duran ◽  
...  

2021 ◽  
Vol 2 (2) ◽  
pp. 52-63
Author(s):  
Ana Jeremić ◽  
Dragana Vuković ◽  
Srna Subanović ◽  
Jovana Broćić ◽  
Biljana Macanović

The application of preimplantation genetic testing (PGT) began in the late 1980s. Pre-implantation genetic testing, as the earliest possible method of prenatal diagnosis, enables the selection of embryos with a normal karyotype for embryo transfer. The use of preimplantation genetic testing has proven to be a useful method in the following three groups of inherited diseases: monogenic disorders (single gene defects), trinucleotide repeat disorders, and chromosomal abnormalities. The success rate of in vitro fertilization (IVF) has increased significantly since the introduction of PGT into clinical practice. This paper presents a literature review with the aim of clearly determining the role of PGT in embryo selection before embryo transfer, as well as the role of this type of testing in increasing the success rate of IVF. One of the goals of the paper is also to review the development of molecular genetic methods that are currently, or have once been, in routine use when performing PGT. The current literature is an indicator of the development and progress of molecular genetics techniques applied in PGT. At the same time, it provides an opportunity and an incentive for further extensive research that will lead to the improvement of preimplantation genetic testing and thus increase the success rate of in vitro fertilization.


Sign in / Sign up

Export Citation Format

Share Document